Menu Menu

PSTX    Poseida Therapeutics Inc    1661460    
Income Statement
Revenue 71,748,000
Net Income 20,235,000
Profit Margin 28.2%

Balance Sheet
Current Assets 250,704,000
Assets 293,577,000
Current Liabilities 78,269,000
Liabilities 206,366,000
Equity 87,211,000
Shares Out 97,134,000

Cash Flow Statement
Operating Cash Flow 13,721,000
Investing Cash Flow -9,552,000

Market Analysis
Market Cap 319,525,322
BVPS 0.90
PB 0.74
EPS -1.19
PS 1.11
FCF 4,169,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
3/07
Apr May Jun
5/14 -0.25
Jul Aug Sep
8/05 -0.32
Oct Nov Dec
11/07

Find a discrepancy? The most accurate way to find company fundamental data is to view PSTX documents filed with the SEC.


PSTX Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: